LCTX - Lineage Cell Therapeutics GAAP EPS of -$0.03 beats by $0.01 revenue of $3.23M beats by $1.04M
2023-08-10 16:37:41 ET
- Lineage Cell Therapeutics press release ( NYSE: LCTX ): Q2 GAAP EPS of -$0.03 beats by $0.01 .
- Revenue of $3.23M (-29.8% Y/Y) beats by $1.04M .
For further details see:
Lineage Cell Therapeutics GAAP EPS of -$0.03 beats by $0.01, revenue of $3.23M beats by $1.04M